Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.044 | 0.7 |
mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |